Gene · 151888
Papers3,415
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,415
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| BTLA and PD-1 combined with radiotherapy for enhancing antitumor immune response in lung cancer via the regulation of memory B cells to promote T-cell infiltration. | Transl Lung Cancer Res | 2026 | 42291367 | PubTator, text mining | PubMed |
| Polymorphisms in immune checkpoint genes might influence bladder cancer risk and clinical outcome. | Hum Immunol | 2026 | 42284619 | PubTator, text mining | PubMed |
| Advances in Immune Checkpoint Inhibitors for Cancer Treatment. | Cancers (Basel) | 2026 | 42279386 | PubTator, text mining | PubMed |
| Interleukin-2 transcriptomic expression correlates with prolonged survival and with GNAS alterations in patients with advanced cancers. | ESMO Open | 2026 | 42263481 | PubTator, text mining | PubMed |
| Triple-Negative Breast Cancer: Molecular Subtypes; Immune Escape; Limitations of Current Immunotherapy; and the BTLA/HVEM/CD160 Axis as an Emerging Target. | Curr Issues Mol Biol | 2026 | 42193138 | PubTator, text mining | PubMed |
| Synergistic immunomodulatory combinations induce robust human tolerogenic dendritic cells for antigen-specific regulatory T cell generation. | J Pharmacol Exp Ther | 2026 | 42184694 | PubTator, text mining | PubMed |
| Siglec-G on B cells restrains the germinal center response by controlling T cell help during positive selection. | bioRxiv | 2026 | 42182281 | PubTator, text mining | PubMed |
| Multiplex profiling of 16 immune checkpoints identifies novel serum biomarker panels for breast cancer detection and TNBC stratification: A case-control study. | PLoS One | 2026 | 42154738 | PubTator, text mining | PubMed |
| ARID1A mutation is associated with an immunosuppressive microenvironment and poor prognosis in hepatocellular carcinoma: An integrated bioinformatics analysis. | Immunobiology | 2026 | 42139761 | PubTator, text mining | PubMed |
| Single cell profiling reveals malignant states and immune landscapes in PCNSL and systemic DLBCL. | iScience | 2026 | 42023148 | PubTator, text mining | PubMed |
| cTfh Cell Activation and Changes in BTLA and LAG-3 Expression Differentially Associate With Poor Pregnancy Outcome in Plasmodium falciparum Placental Malaria. | J Immunol Res | 2026 | 41983955 | PubTator, text mining | PubMed |
| Baseline Th17/Tc17 and LAG-3 levels serve as candidate exploratory markers for early ixekizumab response in psoriasis. | Front Immunol | 2026 | 41972171 | PubTator, text mining | PubMed |
| SPTBN2 promotes an immunosuppressive tumor microenvironment and cross-resistance to anti-cancer therapies. | bioRxiv | 2026 | 41959129 | PubTator, text mining | PubMed |
| Emerging immune checkpoint targets and combination strategies in blood cancer immunotherapy. | Ann Hematol | 2026 | 41915070 | PubTator, text mining | PubMed |
| MSTN and TCF12 as Candidate Immunometabolic Signatures in Glioma-Associated Foam Cells: Insights from Integrated Multi-Omics Analysis. | Curr Issues Mol Biol | 2026 | 41899441 | PubTator, text mining | PubMed |
| Systemic Treatment for Hepatocellular Carcinoma Recurrence After Liver Transplantation. | Curr Oncol | 2026 | 41892169 | PubTator, text mining | PubMed |
| Frontotemporal network interactions causally support rapid concreteness judgments during reading. | PLoS Biol | 2026 | 41880289 | PubTator, text mining | PubMed |
| Machine learning-based predictive models and subtypes patterns in peripheral blood of schizophrenia based on a machine learning computational framework. | Schizophrenia (Heidelb) | 2026 | 41876515 | PubTator, text mining | PubMed |
| Immune checkpoint imbalance in ANCA-associated vasculitis: insights into disease activity and precision immunotherapy. | Front Med (Lausanne) | 2026 | 41846900 | PubTator, text mining | PubMed |
| Integrated analysis identifies a CXCR6/CD45/PD-1-based risk model for melanoma prognosis and intratumoral CD8+/CD69 + T-cell infiltration correlation. | Cell Oncol (Dordr) | 2026 | 41843274 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/151888/papers?page=2